Evidence map›Paper›PMID 24373613›Full record

ArticleBMC microbiology2013

The murine lung microbiome in relation to the intestinal and vaginal bacterial communities.

Kenneth Klingenberg Barfod, Michael Roggenbuck, Lars Hestbjerg Hansen, Susanne Schjørring, Søren Thor Larsen, Søren Johannes Sørensen, Karen Angeliki Krogfelt

Abstract readComparative Study
In one paragraph

Article in BMC microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Use of Subtherapeutic Tylvalosin AgainstTransboundary and emerging diseases · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Frontiers in cellular and infection microbiology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kenneth Klingenberg BarfodStatens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark. kkb@nrcwe.dk.
Michael Roggenbuck
Lars Hestbjerg Hansen
Susanne Schjørring
Søren Thor Larsen
Søren Johannes Sørensen
Karen Angeliki Krogfelt

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis work provides the first description of the bacterial population of the lung microbiota in mice. The aim of this study was to examine the lung microbiome in mice, the most used animal model for inflammatory lung diseases such as COPD, cystic fibrosis and asthma.Bacterial communities from broncho-alveolar lavage fluids and lung tissue were compared to samples taken from fecal matter (caecum) and vaginal lavage fluid from female BALB/cJ mice.

resultsUsing a customized 16S rRNA sequencing protocol amplifying the V3-V4 region our study shows that the mice have a lung microbiome that cluster separately from mouse intestinal microbiome (caecum). The mouse lung microbiome is dominated by Proteobacteria, Firmicutes, Actinobacteria, Bacteroidetes and Cyanobacteria overlapping the vaginal microbiome. We also show that removal of host tissue or cells from lung fluid during the DNA extraction step has an impact on the resulting bacterial community profile. Sample preparation needs to be considered when choosing an extraction method and interpreting data.

conclusionsWe have consistently amplified bacterial DNA from mouse lungs that is distinct from the intestinal microbiome in these mice. The gut microbiome has been extensively studied for its links to development of disease. Here we suggest that also the lung microbiome could be important in relation to inflammatory lung diseases. Further research is needed to understand the contribution of the lung microbiome and the gut-lung axis to the development of lung diseases such as COPD and asthma.

Indexed as

MicrobiotaAnimalsBacteriaBronchoalveolar Lavage FluidDNA, BacterialDNA, RibosomalFecesFemaleGastrointestinal TractLungMetagenomeMiceMice, Inbred BALB CRNA, Ribosomal, 16SSequence Analysis, DNAVaginaDNA, BacterialDNA, RibosomalRNA, Ribosomal, 16S

Identifiers

PMID24373613
PMCPMC3878784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.